The BRI Blog
For recent medical community news and insights, engage with our recent posts below.
Sally Pipes: “The ‘Medicare-For-All’ Delusion”
January 26, 2026 by bmew
Is the nation in a place to allocate $30-$35 trillion in new federal spending for the first decade of a policy which results in resources, shortages, delays, rationing, and worse care for patients everywhere it’s tried?
January 22, 2026 by bmew
A study published this week by the Pacific Research Institute found that the return on capital for health insurers and PBMs is four times higher than it is for drug manufacturers. Yet, so often, we’re told biopharmaceutical companies are the ones earning excessive returns.
Sally Pipes: “Enhanced Obamacare Subsidies are Gone. They Deserve to Stay That Way.”
January 22, 2026 by bmew
The enhanced premium subsidies are wasteful and expensive; they benefit a sliver of the population; and they enrich health insurers despite widespread evidence of fraud.
Sally Pipes: “Congress Must Prioritize Patients, Not Insurers, In Renewed Healthcare Debate”
January 13, 2026 by bmew
Now is not the time to revisit Obamacare’s enhanced subsidies. Now is the time to enact real reforms in the health care industry itself–starting with routing the abundant fraud.
Sally Pipes: Terrible Effects of Medicare Price Controls Are Here
December 29, 2025 by bmew
Price caps do more than just reduce revenue for drugmakers. They also discourage investment in the research and development of promising treatments and therapies.
Sally Pipes: Patent Taxes Threaten America’s Most Productive Engine of Growth
December 23, 2025 by bmew